| Literature DB >> 27544821 |
Garrett Edward Berry1, Aravind Asokan2.
Abstract
Recombinant adeno-associated viral vectors (rAAV) are regarded as promising vehicles for therapeutic gene delivery. Continued development and new strategies are essential to improve the potency of AAV vectors and reduce the effective dose needed for clinical efficacy. In this regard, many studies have focused on understanding the cellular transduction mechanisms of rAAV, often with the goal of exploiting this knowledge to increase gene transfer efficiency. Here, we provide an overview of our evolving understanding of rAAV cellular trafficking pathways through the host cell, beginning with cellular entry and ending with transcription of the vector genome. Strategies to exploit this information for improving rAAV transduction are discussed. Copyright ÂEntities:
Mesh:
Year: 2016 PMID: 27544821 PMCID: PMC5138113 DOI: 10.1016/j.coviro.2016.08.001
Source DB: PubMed Journal: Curr Opin Virol ISSN: 1879-6257 Impact factor: 7.090